Trial no.:
|
PACTR202002648274347 |
Date of Approval:
|
12/02/2020 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Efficacy of extracorporeal shock wave therapy (ESWT) on cervical myofascial pain following neck dissection surgery. |
Official scientific title |
Efficacy of extracorporeal shock wave therapy (ESWT) on cervical myofascial pain following neck dissection surgery. |
Brief summary describing the background
and objectives of the trial
|
Myofascial pain syndrome (MPS) is a musculoskeletal disorder which is characterized by pain, muscle spasms and muscle tenderness, as well as a limited range of motion, weakness, and rarely, autonomous dysfunction.
The occurrences of morbidity of the neck after cancer therapy were considerable and consisted of neck pain, loss of sensation, and decreased range of motion. Extracorporeal shock wave therapy (ESWT) is one of the treatment options used for patients with myofascial pain syndrome through elimination of ischemia and modulation of vasoneuroactive substance (two major causes of trigger pathophysiology) and mechanical transduction as a cellular response to external stimulation. the aim of this study was to investigate efficacy of extracorporeal shock wave therapy (ESWT) on cervical myofascial pain following neck dissection surgery.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Musculoskeletal Diseases |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Devices |
Anticipated trial start date |
03/03/2019 |
Actual trial start date |
03/03/2019 |
Anticipated date of last follow up |
01/04/2019 |
Actual Last follow-up date |
01/04/2019 |
Anticipated target sample size (number of participants) |
46 |
Actual target sample size (number of participants) |
46 |
Recruitment status |
Completed |
Publication URL |
|
|